Viking CEO Brian Lian says its obesity drug is about 2.5 years from launch
Speaking on the Q3 2026 earnings call, Lian gave a timeline that points to a possible 2029 launch for Viking's weight loss candidate.
Recap by typeshit. Full story at Zacks Investment Research on MSN.